Author: George Underwood

Novartis has hit out at Bayer with an analysis that shows its eye drug Lucentis is more cost effective than the German firm’s Eylea for the treatment of diabetic macular oedema (DMO) in the UK

Fire fighters, hairdressers, postal workers and other occupations could all support efforts to improve the public’s health, according to plans outlined by the Royal Society for Public Health (RSPH) in a new report.

Demand for over-the-counter (OTC) medicines in the UK has grown in the last year, according to a new report.

Demand for over-the-counter (OTC) medicines in the UK has grown in the last year, according to a new report.

An all party parliamentary group (APPG) has been established to raise the profile of the UK life sciences sector.